๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Nephroblastoma

Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation NCT04968990Phase 21 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Proton Beam Radiation (PBRT), DD-4A Chemotherapy Regimen, Complete Surgical Resection, Surgical Resection, Partial Nephโ€ฆ Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma NCT05765084Phase 1, Phase 23 sites๐Ÿ“ Edegem๐Ÿ“ Ghent๐Ÿ“ Sint-Niklaas University Hospital, Antwerp ยท Tests: Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: SC-CAR.GPC3xIL15.21 CAR T cells Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT NCT04322318Phase 2205 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage Children's Oncology Group ยท Tests: Biopsy Procedure, Biospecimen Collection, Bone Scan, Carboplatin, Computed Tomography Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT) NCT07796061Phase 11 site๐Ÿ“ Washington D.C. Children's National Research Institute ยท Tests: TAA-T Cell, BBB Disruption B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor NCT06456359Phase 24 sites๐Ÿ“ Heidelberg๐Ÿ“ Stuttgart๐Ÿ“ Stuttgart University Hospital Heidelberg ยท Tests: Signifor FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia NCT07645469Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells, Azacitidine, Biospecimen Collection,โ€ฆ Lurbinectedin in FET-Fused Tumors NCT05918640Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Iowa City๐Ÿ“ Boston Children's Hospital of Philadelphia ยท Tests: Lurbinectedin A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors NCT05985161Phase 216 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C. Memorial Sloan Kettering Cancer Center ยท Tests: Selinexor A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites๐Ÿ“ Birmingham๐Ÿ“ Aurora๐Ÿ“ Washington D.C. Nationwide Children's Hospital ยท Tests: Cabozantinib Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Washington D.C. St. Jude Children's Research Hospital ยท Tests: Onivyde, Talazoparib, Temozolomide Pencil Beam Scanning in Patients With Renal Tumors NCT03810651EARLY Phase 11 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Proton beam radiation using pencil beam scanning Physical Activity and Community EmPOWERment Project NCT06740162NA2 sites๐Ÿ“ Fayetteville๐Ÿ“ Chapel Hill University of North Carolina, Chapel Hill ยท Tests: PACE Program Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange Children's Oncology Group ยท Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) NCT06401330Phase 3169 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage Children's Oncology Group ยท Tests: Bone Scan, Carboplatin, Computed Tomography, Cyclophosphamide, Dactinomycin Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor NCT04616560Phase 232 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging, Multigated Acquisition โ€ฆ Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) NCT07172958Phase 12 sites๐Ÿ“ Washington D.C.๐Ÿ“ Washington D.C. Children's National Research Institute ยท Tests: Selective Antigen Specific dTฮฒRII-expressing T cells combined with B7-H3 CAR T cells Biomarkers of Resiliency In Childhood Cancer Surgery NCT06674811n/a1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Wearing Smartwatch, Patient Report Outcomes, Blood Draw, Clinical Data Review Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) NCT05384821Phase 1, Phase 218 sites๐Ÿ“ Amiens๐Ÿ“ Besanรงon๐Ÿ“ Bordeaux Centre Oscar Lambret ยท Tests: Vincristine, Irinotecan, Temozolomide, Etoposide, Cis-Retinoic acid International PPB/DICER1 Registry NCT03382158n/a1 site๐Ÿ“ Minneapolis Children's Hospitals and Clinics of Minnesota Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330Phase 11 site๐Ÿ“ Valhalla New York Medical College ยท Tests: Vorinostat CUE-102 in Recurrent Glioblastoma NCT06917885Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston David Reardon, MD ยท Tests: CUE-102 Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: 21.15.GPC3-CAR T cells Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors NCT04715191Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: CARE T cells Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Miltenyi CliniMACS Prodigy ยฎ system, Zoledronic acid Therapeutic Recommendations for Nephroblastoma NCT04423484n/a7 sites๐Ÿ“ Ouagadougou๐Ÿ“ Abidjan๐Ÿ“ Kinshasa French Africa Pediatric Oncology Group ยท Tests: Data collection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy